Nightingale CBD strain is a cross of Harlitsu and a west coast strain to give you a great fruity tasting CBD strain tasting of grape, blueberry and jasmine. Nightingale is bred to keep a low THC content, between (1-3%) and give the patient a higher CBD content (11-18%) which will help to treat a small infant to a elderly person. This particular CBD strain produces more than an average yield. The buds will tend to be red/purple in colour, Be aware of this strain stretching, she has been found to have better results in scrog or sog (sea of green). Medical benefits: Helps to treat Crohn's Disease, Epilepsy, Arthritis, Cancer and other autoimmune disorders.
Strain FAQ
What therapeutic benefits do low THC strains provide without psychoactivity?
For anxiety and inflammation sufferers, low THC strains reportedly provide relief. They are said to provide relaxing comfort without the cognitive cloud of THC, making them often a go-to for daily relief.
What makes Central Asian cannabis strains landrace-based?
Central Asian landrace cannabis strains have evolved over millennia. Natural selection has adapted these strains to Central Asia's severe environment. Their pure, highly adapted genetic blueprint shows the cannabis plant's resilience and diversity.
How do breeders create grape-flavored cannabis?
Grape flavour derives from selective breeding for genetic features. Breeders can create grape-scented offspring by selecting and crossing parent strains like Granddaddy Purple, Purple Urkle, and Grape Ape.
Is controlling pests and disease easier indoors?
Indoor cannabis areas are like fortresses against pests and infections. Legal indoor growers are said to avoid many of the problems that outside farmers experience on a regular basis which reportedly results in healthier plants and purer goods. This is done through strictly controlling who (or what) enters the space and maintaining pristine conditions.
How will cannabis therapy evolve?
With so many strains and pharmacological characteristics, personalised cannabis treatment has a bright future. Patients and doctors can choose strains that are said to target their ailments, enabling more personalised cannabis therapy.